open multicenter trial recombinant tissue plasminogen activator acute stroke progress report rt-PA Acute Stroke Study Group Sixteen clinical centers countries prospective open angiography- tomography scan-based safety efficacy dose-rate finding study recombinant two-chain tissue plasminogen activator rt-PA acute thrombotic thromboembolic stroke Preliminary experience rt-PA treated patients dose-rate groups partial complete recanalization angiography dose response Hemorrhagic infarction dose rates dose-rate independent cerebral hematomas study dose rates safety guidelines 